Datos en vida real: una visión más completa de la patología - page 6

Do we need RWE?
‘Unmet needs’
Rare diseases (i.e. tail of mutations in a given cancer) are a challenge
to perform standard clinical trials and RWE may help “approval”
Understand patterns of use of clinical trial advances
Increasing view-need to monitor the clinical value in routine practice
of economical investment in anti-cancer treatments
1,2,3,4,5 7,8,9,10,11,12,13,14,15,16,...29
Powered by FlippingBook